Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

Only 40% of Medicare Advantage health prescription drug plans achieved a four-star rating or higher under the current criteria used by Centers for Medicare and Medicaid Services to grade quality. The ...

Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by ...

Elevance is a high-quality stock with consistent EPS growth, trading at a significant discount to peers like UnitedHealth.

The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...

Medicare Advantage plans are government Medicare benefits provided through for-profit insurers, so plan terms can — and do — change ...

Below is a roundup of payer-centric news headlines you may have missed during the month of October 2024. | In this month's ...

Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026, ...

CVS Health subsidiary Aetna holds 88% percent of members in plans rated four or more, down from 90.8%. CMS will designate ...

CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...